Small Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer

Cancer Research - United States
doi 10.1158/0008-5472.can-17-1973
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Chemotherapy and Tumor Microenvironment of Pancreatic Cancer

Cancer Cell International
Cancer ResearchOncologyGenetics
2017English

Small Molecule Tyrosine Kinase Inhibitors in Pancreatic Cancer

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

Computer Aided Small Molecule Modulation of Pancreatic Cancer Mechanobiology

Biophysical Journal
Biophysics
2019English

Improving Cancer Immunotherapy by Targeting Tumor-Induced Immune Suppression

Cancer and Metastasis Reviews
Cancer ResearchOncology
2011English

Protein–protein Interactions as Targets for Small-Molecule Therapeutics in Cancer

Expert Reviews in Molecular Medicine
Molecular MedicineMolecular Biology
2008English

Inhibition of Integrin-Linked Kinase by a Selective Small Molecule Inhibitor, QLT0254, Inhibits the PI3K/PKB/mTOR, Stat3, and FKHR Pathways and Tumor Growth, and Enhances Gemcitabine-Induced Apoptosis in Human Orthotopic Primary Pancreatic Cancer Xenografts

Cancer Research
Cancer ResearchOncology
2005English

Inhibition of USP2 Eliminates Cancer Stem Cells and Enhances TNBC Responsiveness to Chemotherapy

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

Exosomes and Tumor-Mediated Immune Suppression

Journal of Clinical Investigation
Medicine
2016English

Codelivery of Small Molecule Hedgehog Inhibitor and miRNA for Treating Pancreatic Cancer

Molecular Pharmaceutics
Drug DiscoveryMolecular MedicinePharmaceutical Science
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy